Biomolecular NMR Assignments is a prominent academic journal dedicated to advancing the field of biomolecular nuclear magnetic resonance (NMR) spectroscopy. Published by SPRINGER, this journal aims to provide a platform for researchers to share significant findings, methodological advancements, and in-depth analyses related to protein structure, dynamics, and interactions through NMR techniques. Although not currently open access, it serves as a valuable resource for those in the fields of Biochemistry and Structural Biology, having established a respectable impact factor reflected in its category rankings within these disciplines. With its coverage spanning from 2007 to 2024, Biomolecular NMR Assignments continues to facilitate the exchange of knowledge among professionals and students, contributing to the growth and enhancement of contemporary scientific inquiry. Explore the intricacies of biomolecular studies in the Netherlands and beyond, where critical insights into molecular behavior and function converge.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, published by Elsevier, serves as a pivotal journal in the fields of biochemistry and biophysics, with a long-standing history dating back to 1956. This esteemed publication, bearing the ISSN 0304-4165 and E-ISSN 1872-8006, continuously contributes to advancing our understanding of complex biological processes through rigorous research articles and reviews. It notably holds a distinguished position with a Q2 classification in Biochemistry and a Q1 ranking in Biophysics for 2023, reflecting its high relevance and impact within these scientific domains. The journal is also recognized within the Scopus metrics, taking a rank of #40 out of 152 in Biophysics and #173 out of 438 in Biochemistry, thus placing it in the 74th and 60th percentiles respectively. Academics and professionals in the life sciences will find this journal an essential resource for current research, cutting-edge techniques, and comprehensive reviews aimed at enhancing the understanding of biological functions. While BIOCHIMICA ET BIOPHYSICA ACTA is not an open-access journal, it remains a cornerstone publication for those seeking to stay at the forefront of biochemical and biophysical research.

JOURNAL OF BIOSCIENCES, published by the Indian Academy of Sciences, has established itself as a pioneering platform in the fields of biosciences, encompassing diverse research areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and medicine. With an impressive trajectory since its inception in 1979, the journal has achieved notable recognition, securing a Q1 ranking in Agricultural and Biological Sciences and maintaining its place in the top quartiles for Biochemistry and Medicine as of 2023. With Scopus rankings placing it at #32 in General Agricultural and Biological Sciences and #65 in General Biochemistry, Genetics, and Molecular Biology, the journal reaches the 85th and 70th percentiles respectively, reflecting its impact and relevance in current scientific discourse. Although it does not offer open access, the JOURNAL OF BIOSCIENCES remains crucial for researchers, professionals, and students dedicated to advancing knowledge and innovation within the biosciences, providing a vibrant forum for high-quality research and comprehensive reviews.

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

BIOCHEMISTRY is a premier academic journal published by the American Chemical Society, dedicated to advancing the field of biochemistry through the dissemination of high-quality research. With an ISSN of 0006-2960 and an e-ISSN of 1520-4995, this esteemed publication has been a vital resource since its inception in 1962 and continues to contribute to the scientific community, boasting a remarkable Q1 ranking in the field as of 2023. The journal's well-curated content emphasizes fundamental biochemical research, molecular genetics, and innovations in biochemical techniques, catering to a diverse audience of researchers, professionals, and students. Although not an open-access publication, BIOCHEMISTRY plays a crucial role in facilitating knowledge exchange and fostering academic collaboration globally, making significant contributions to the understanding of the biochemical processes that underpin life.

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

The EMBO JOURNAL, published by Wiley in Germany, is a renowned scientific journal that has been at the forefront of research in the fields of biochemistry, genetics, and molecular biology since its inception in 1982. With an impressive convergence of contributions leading up to 2024, this journal is recognized for its high impact, reflected in its Q1 rankings across multiple categories including Immunology, Molecular Biology, and Neuroscience. It holds a prestigious place in the academic community, standing out with an exemplary Scopus ranking of #3 in General Immunology and Microbiology and #6 in General Neuroscience, making it a critical resource for researchers, professionals, and students alike. The journal aims to publish transformative research that sheds light on the underlying mechanisms of biological processes, thus advancing our understanding of health and disease. While currently not offering open access, the EMBO JOURNAL continues to facilitate a rich exchange of knowledge through its rigorous peer-review process and commitment to excellence.

Open Biology is a prestigious, interdisciplinary journal published by the Royal Society that has been paving the way in the fields of Biochemistry, Genetics and Molecular Biology, Immunology, and Neuroscience since its inception in 2011. Catering to a global audience of researchers, professionals, and students, Open Biology operates under an open access model, facilitating the unrestricted dissemination of high-quality research findings. With a current impact factor that positions its categories in the top quartile (Q1) and impressive Scopus rankings—evidencing its influence and reach—this journal serves as a vital platform for innovators and scientific inquiries aimed at advancing our understanding of life sciences. The journal's commitment to publishing cutting-edge research makes it an essential resource for those at the forefront of scientific exploration.